关键词：牛皮癣；表皮增生；皮肤炎症；免疫性疾病
摘 要：Psoriasis is a chronic inflammatory disease of the skin. It is a skin disorder characterized by epidermal hyper proliferation and dermal inflammation that differ in severity, from small, confined patches to complete body coverage. It affects approximately 2–3 percent of the population, making it one of the most prevalent autoimmune diseases worldwide. In this disease skin cells replicate at an exceptionally rapid rate, about eight times faster than the normal skin cells. This results in the build-up of cells on the skin's surface forming thick patches or plaques. It is a lifelong skin disease that begins in the immune system, mainly with a type of white blood cell called a T-cell. T-cells help protect the body against infection and disease. In psoriasis, T-cells are set into action by error and they turn out to be so active that they start out other immune responses. This results into swelling and quick turnover of skin cells. There is no cure for psoriasis. But numerous topical, systemic, and biologic therapies are available for the treatment of mild psoriasis or controlling the severe psoriasis. Treatment modalities are chosen on the basis of disease severity, cost, efficacy, patient preference, and evaluation of individual patient response.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Types of Psoriasis

06.1 Types of Psoriasis Based on Forms

Plaque Psoriasis

Guttate Psoriasis

Inverse Psoriasis

Erythrodermic psoriasis

Pustular Psoriasis

06.2 Types of Psoriasis Based on Severity of Disease

07. Market Landscape

07.1 Global Psoriasis Therapeutics Market

Market Size and Forecast

07.2 Global Mild Psoriasis Therapeutics Market

07.3 Global Moderate Psoriasis Therapeutics Market

07.4 Global Severe Psoriasis Therapeutics Market

07.5 Five Forces Analysis

08. Geographical Segmentation

09. Rate of Incidence and Prevalence

Global Incidence and Prevalence

America

The UK

Asia

 10. Pipeline Analysis

10.1 Pipeline Analysis of Topical Psoriasis Drugs

10.2 Pipeline Analysis of Oral Psoriasis Drugs

10.3 Pipeline Analysis of Injectable Psoriasis Drugs

11. Vendor Landscape

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Key Vendor Analysis

18.1 Abbvie Inc.

Business Overview

Key Information

 SWOT Analysis

18.2 Amgen Inc.

Business Overview

Key Information

SWOT Analysis

18.3 Janssen Biotech Inc.

Business Overview

Key Information

SWOT Analysis

18.4 Novartis International AG

Business Overview

4Key Information

 SWOT Analysis

18.5 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

19. Other Reports in this Series